RYTM
Rhythm Pharmaceuticals, Inc.
Stock
$92.83−0.58 (−0.62%)Close Oct 2, 2026
- Revenue, 2025
- $190M
- YoY, 2025
- +45.8%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $190M | +45.8% |
| 2024 | $130M | +68.1% |
| 2023 | $77M | +227.6% |
| 2022 | $24M | +649.5% |
| 2021 | $3.2M | — |
| 2020 | $0 | — |
| 2019 | $0 | — |
| 2018 | $0 | — |
| 2017 | $0 | — |
| 2016 | $0 | — |